23/02/2017
M&S Decisions presented the work made in collaboration with AstraZeneca “Model-based meta-analysis of safety for immune checkpoint inhibitor combinations and monotherapy” at ASCO-SITC Immuno-Oncology Symposium in Orlando, the USA.
M&S Decisions made scientific presentation in collaboration with AstraZeneca at ASCO-SITC Immuno-Oncology Symposium in Orlando, USA
